Extension Study of IMO-8400 in Patients With Waldenström's Macroglobulinemia Who Completed Study 8400-401
Clinical trial NCT02363439 · COMPLETED
Trial details
- NCT number
- NCT02363439
- Sponsor
- Idera Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-11-01
- Primary completion
- 2016-12-01
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.